Active Ingredient: Pembrolizumab (humanized IgG4 monoclonal antibody targeting PD-1) Strength: 100 mg per 4 mL (25 mg/mL) concentrate for solution for infusion Dosage Form: Sterile concentrate for intravenous infusion Packaging: Single-use vial (typically 4 mL) Storage: Refrigerate at 2–8°C (36–46°F); protect from light; do not freeze or shake Indication(for reference only): Multiple oncology indications (e.g., advanced melanoma, NSCLC, head and neck cancer, etc.) — consult official labeling Manufacturer: Merck Sharp & Dohme (or authorized biosimilar producer if applicable) Shelf Life: Typically 24–36 months (check batch-specific) Route of Administration: Intravenous infusion over 30 minutes Other: Prescription only; cold chain shipping required; regulatory approvals (e.g., FDA, EMA, etc.)
